UBS Group
OGN icon

UBS Group’s Organon & Co OGN Stock Holding History

UBS Group’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-72,100
Closed -$1.36M – 9933
2024
Q1 		$1.36M Buy
+72,100
New +$1.24M ﹤0.01% 4333
2022
Q1 		– Sell
-50
Closed -$2K – 10704
2021
Q4 		$2K Sell
50
-1,440
-97% -$46.9K ﹤0.01% 9818
2021
Q3 		$49K Sell
1,490
-301
-17% -$9.63K ﹤0.01% 6354
2021
Q2 		$54K Buy
+1,791
New +$59K ﹤0.01% 6357

Other funds holding OGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

UBS Group's OGN Position: Q1 2026 in Review

UBS Group reduced its Organon & Co (OGN) stake by 19% in Q1 2026, selling an estimated $6.2M and leaving 3,471,579 shares worth $20.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2534.

UBS Group first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $57.7M in Q2 2025. 604 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • UBS Group held 3,471,579 shares of Organon & Co worth $20.8M as of Q1 2026.
  • UBS Group sold 823,423 Organon & Co shares in Q1 2026, an estimated $6.2M.
  • Organon & Co made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2534 holding.
  • UBS Group first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • UBS Group's Organon & Co position peaked at $57.7M in Q2 2025.
  • 604 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.